Sawatani, Y.; Komiyama, Y.; Nakashiro, K.-i.; Uchida, D.; Fukumoto, C.; Shimura, M.; Hasegawa, T.; Kamimura, R.; Hitomi-Koide, M.; Hyodo, T.;
et al. Paclitaxel Potentiates the Anticancer Effect of Cetuximab by Enhancing Antibody-Dependent Cellular Cytotoxicity on Oral Squamous Cell Carcinoma Cells In Vitro. Int. J. Mol. Sci. 2020, 21, 6292.
https://doi.org/10.3390/ijms21176292
AMA Style
Sawatani Y, Komiyama Y, Nakashiro K-i, Uchida D, Fukumoto C, Shimura M, Hasegawa T, Kamimura R, Hitomi-Koide M, Hyodo T,
et al. Paclitaxel Potentiates the Anticancer Effect of Cetuximab by Enhancing Antibody-Dependent Cellular Cytotoxicity on Oral Squamous Cell Carcinoma Cells In Vitro. International Journal of Molecular Sciences. 2020; 21(17):6292.
https://doi.org/10.3390/ijms21176292
Chicago/Turabian Style
Sawatani, Yuta, Yuske Komiyama, Koh-ichi Nakashiro, Daisuke Uchida, Chonji Fukumoto, Michiko Shimura, Tomonori Hasegawa, Ryouta Kamimura, Masayo Hitomi-Koide, Toshiki Hyodo,
and et al. 2020. "Paclitaxel Potentiates the Anticancer Effect of Cetuximab by Enhancing Antibody-Dependent Cellular Cytotoxicity on Oral Squamous Cell Carcinoma Cells In Vitro" International Journal of Molecular Sciences 21, no. 17: 6292.
https://doi.org/10.3390/ijms21176292
APA Style
Sawatani, Y., Komiyama, Y., Nakashiro, K.-i., Uchida, D., Fukumoto, C., Shimura, M., Hasegawa, T., Kamimura, R., Hitomi-Koide, M., Hyodo, T., & Kawamata, H.
(2020). Paclitaxel Potentiates the Anticancer Effect of Cetuximab by Enhancing Antibody-Dependent Cellular Cytotoxicity on Oral Squamous Cell Carcinoma Cells In Vitro. International Journal of Molecular Sciences, 21(17), 6292.
https://doi.org/10.3390/ijms21176292
